616881-75-5Relevant academic research and scientific papers
PYRIDO-PYRIMIDINYL COMPOUNDS AND METHODS OF USE
-
Paragraph 0826-0827, (2020/09/08)
Provided herein are compounds of formula (I) and pharmaceutically acceptable salts thereof useful in the treatment of IRE 1-related diseases and disorders described herein.
N-HYDROXYMETHANESULFONAMIDE NITROXYL DONORS
-
Paragraph 0543, (2016/03/12)
The disclosed subject matter provides N-hydroxymethanesulfonamide compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter pr
N-HYDROXYMETHANESULFONAMIDE NITROXYL DONORS
-
Page/Page column 86-87, (2015/08/03)
The disclosed subject matter provides N-hydroxymethanesulfonamide compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter pr
SUBSTITUTED (THIAZOL-2-YL) -AMIDE OR SULFONAMIDE AS GLYCOKINASE ACTIVATORS USEFUL IN THE TREATMENT OF TYPE 2 DIABETES
-
Page 33, (2010/02/07)
Compounds of the formula (I) provide pharmacological agents which are glucokinase activators and thus may be employed for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for prevention and treatm
